Pitavastatin reduces incident hypertension risk in individuals with HIV Infectious Disease Advisor 8h Hypertension The Lancet Global Health
Merck, Gilead score in effort to develop the first weekly HIV pill FiercePharma 1d Merck and Co Pharma
Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials Clinical Trials Arena 14h Gilead Sciences Pharma Biotech
Gilead and Merck announce positive topline results from two phase 3 studies evaluating islatravir/Lenacapavir, an oral once-weekly HIV treatment Business Wire (Press Release) 2d Gilead Sciences Merck and Co FDA
Disability, disease and death warning for anyone drinking alcohol The Mirror 15h Disability Health Science Article paywall
Tea is good for health but the way you drink it matters, study says The Independent 17h Pesticides Microplastics Agriculture Article paywall
Natural compound that temporarily reverses advanced dementia symptoms The Independent 3d Dementia Alzheimer's Neuroscience Article paywall
Health workers at the epicenter of Congo's Ebola outbreak labour with little pay or rest AsiaOne 3d Ebola DR Congo Africa
